{
    "id": "6025e2641cb411341a0000bb",
    "question": "Can thiotepa be recommended for treatment of osteosarcoma?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"Thiotepa is a chemotherapy medication that was historically used to treat various types of cancer, including leukemia and lymphoma. However, it is not commonly used today due to its high toxicity and the availability of more effective and safer alternatives. Osteosarcoma is a type of bone cancer that typically requires a combination of surgery, chemotherapy, and radiation therapy for treatment. The primary chemotherapy agents used in the treatment of osteosarcoma include doxorubicin, methotrexate, and cisplatin. Thiotepa is not typically considered a standard treatment option for osteosarcoma. Its use in this context would be highly unusual and may not provide significant benefits due to its toxicity profile. In contrast, other chemotherapy agents that are more commonly used in osteosarcoma treatment have a more favorable risk-benefit ratio. Therefore, based on current medical knowledge and treatment guidelines, thiotepa is not a recommended treatment option for osteosarcoma.\", \"answer_choice\": \"B\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 21.18172311782837
}